Science & Research
LNS8801 Enters NIA Interventions Testing Program for Longevity Research
Dual selection by NIA ITP and ARPA-H PROSPR signals growing institutional validation for longevity-targeting compounds …
Science & Research 17 stories
Science & Research
Actuate Therapeutics' Elraglusib Enters Pediatric Oncology Platform Trial
The GSK-3β inhibitor joins a Cancer Research UK-sponsored multi-arm trial after a complete response was recorded in a p…
Science & Research
FloBiotech Partners with UCLA Health on Neurodegeneration Pathway Therapeutics
The Basel-based biotech's move signals growing crossover between nutraceutical-adjacent pathway science and clinical ne…
Science & Research
CAR-T Therapy LYL273 Advances to Phase 1/2 in Colorectal Cancer
The amendment signals regulatory confidence in next-generation cell therapy manufacturing as solid-tumor CAR-T programs…
Science & Research
Memo Therapeutics Phase II Data on BKPyV Antibody Presented at ERA
The oral presentation marks a clinical milestone for polyclonal antibody therapies targeting post-transplant viral comp…